Latest Breaking News On - Catherine novack - Page 1 : comparemela.com

Daré Bioscience, Inc (NASDAQ:DARE) Q3 2023 Earnings Call Transcript

Operator: Welcome to the conference hosted by Daré Bioscience to Review the Company s Third Quarter Financial Results and to provide a General Business Update. This call is being recorded.

United statesCatherine novackSabrina martucci johnsonLisa walters hoffertClinical trials networkNational institute of child healthDare bioscience incHuman developmentBioscience incCall transcript novemberThird quarter financial resultsGeneral businessChief executive officerJohn fairChief commercial officerChief financial

Jones Trading Starts Gritstone Oncology (GRTS) at Buy, see Gritstone as a highly underappreciated story

Jones Trading Starts Gritstone Oncology (GRTS) at Buy, see Gritstone as a highly underappreciated story
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Catherine novackGritstone oncologyGritstone bio

Lumos Pharma, Inc (NASDAQ:LUMO) Q2 2023 Earnings Call Transcript

Operator: Good afternoon, and welcome to Lumos Pharma s Q2 2023 Financial Results Conference Call. Currently, all participants are in a listen-only mode.

United statesLeland gershellFernando cassorlaLisa millerLaura dichtelErick hawkinsYasmeen rahimiCatherine novackPete stavropoulosPiper sandlerMichael tanseyLumos pharmaDuke pitukcheewanontJohn mckewRed whiteLori lawley

Daré Bioscience, Inc (NASDAQ:DARE) Q1 2023 Earnings Call Transcript

Operator: Welcome to the conference call hosted by Daré Bioscience to review the Company’s Financial Results for the Quarter Ended March 31, 2023, and to provide a General Business Update.

United statesUnited kingdomDoug tsaoCatherine novackKumar rajaKemp dolliverSabrina martucci johnsonLisa walters hoffertAcademy of managed care pharmacyJones researchAmerican college of obstetriciansCompany financial results for the quarter endedDare bioscience incBioscience incMarquee conference in women healthCall transcript may

Daré Bioscience, Inc (NASDAQ:DARE) Q4 2022 Earnings Call Transcript

Operator: Welcome to the conference call hosted by DarÃ© Bioscience to review the company s Financial Results for the Year Ended December 31, 2022 and to provide a general business update.

United statesLisa walters hoffertCatherine novackSabrina johnsonSabrina martucci johnsonDare bioscience incAmerican menopause societyBioscience incGynecologists committeeJones researchLargest orthopedic companiesAmerican college of obstetricsCall transcript marchFinancial resultsYear ended decemberChief executive officer